This led us to unravel that ATM and ATR inhibitors represent a strategy particularly suited to jeopardize DDR in acid-exposed cancer cells and exert growth inhibitory effects on this aggressive tumor compartment either as a single agent or in combination with chemotherapy. The gene discussed is ATR; the disease is cancer.